Tristan Free

speaker

289 appearances 6 recordings 1 series first heard Jun 2026 last heard 23 Jul

Tristan Free’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 6 in all, peaking in Jun 2026 with 4.

Appearances

newest first · ▶ plays the moment

Talking Techniques · AI & Antibodies miniseries | Designing smart antibodies in the age of AI · 22 Jun 2026 podcast

So what are some of the ways that institutions um and AI and machine learning software developers can work together to kind of overcome some of those uh current limitations?

It's surprising sometimes where where these sources come from.

I remember um doing a podcast a while ago on spatial biology and and saying that there was a lot of investment going in there from from Google and stuff like that, in but into the the systems around sort of biological spatial biology, and it was kind of hard to understand why where you know, where that crossover was with their systems.

And um I remember the person I was interviewing was saying at the end of the day, a lot of these uh the people running these

Companies all want to be immortal, so they kind of invest in these big, big science things that um uh that they hopefully will will get them there.

Big

So um yeah, it's it's a an interesting sort of source that gets tapped into every now and then.

Um so it's now been just over a year since um the publication of of your article.

I in that time, have you seen any particularly exciting examples of the use of um AI in smart antibodies?

Excellent.

Well, in that vein then, and I know this is a a difficult question to to predict as everything moves so fast, but what are your predictions for the impact of AI on the development of smart antibodies um in the next five years or so?

Excellent.

And uh my final question is if I could ask you for one thing to to help uh advance the design of antibody therapeutics, if I was a genie that could grant you a wish, um, what would it be?

Fantastic.

Well, thank you so much for joining us on the podcast, Andrew.

It it's been really great, I mean, throughout the series to hear um about all the ways that AI is helping in developability, in the kind of avoiding adverse reactions, so the humanization, the binding, and to really have this episode to to go through the kind of overview of all the way that it's uh impacting antibody design and to get such an insightful assessment of the impact that it's having.

Um it's great.

So thank you for joining us.

Um, if you've enjoyed this episode and would like to find more like it, you can check out the podcast section of the site on biotechniques dot com.

Showing 101–120 of 289 · page 6 of 15